95 related articles for article (PubMed ID: 25829192)
1. Ribosomal protein L11- and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells.
Kummalue T; Inoue T; Miura Y; Narusawa M; Inoue H; Komatsu N; Wanachiwanawin W; Sugiyama D; Tani K
Exp Hematol; 2015 May; 43(5):414-423.e1. PubMed ID: 25829192
[TBL] [Abstract][Full Text] [Related]
2. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
[TBL] [Abstract][Full Text] [Related]
3. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
4. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
5. JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35.
Ma R; Hu J; Huang C; Wang M; Xiang J; Li G
Br J Pharmacol; 2014 Jul; 171(13):3234-45. PubMed ID: 24597613
[TBL] [Abstract][Full Text] [Related]
6. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation.
Aerbajinai W; Giattina M; Lee YT; Raffeld M; Miller JL
Blood; 2003 Jul; 102(2):712-7. PubMed ID: 12663450
[TBL] [Abstract][Full Text] [Related]
7. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
Mori M; Uchida M; Watanabe T; Kirito K; Hatake K; Ozawa K; Komatsu N
J Cell Physiol; 2003 May; 195(2):290-7. PubMed ID: 12652655
[TBL] [Abstract][Full Text] [Related]
8. A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway.
Bridoux L; Etique N; Lambert E; Thevenard J; Sowa ML; Belloy N; Dauchez M; Martiny L; Charpentier E
FEBS Lett; 2013 May; 587(10):1524-8. PubMed ID: 23583449
[TBL] [Abstract][Full Text] [Related]
9. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
Fukumoto T; Kubota Y; Kitanaka A; Yamaoka G; Ohara-Waki F; Imataki O; Ohnishi H; Ishida T; Tanaka T
Cell Signal; 2009 Dec; 21(12):1775-83. PubMed ID: 19665053
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2.
Silva M; Grillot D; Benito A; Richard C; Nuñez G; Fernández-Luna JL
Blood; 1996 Sep; 88(5):1576-82. PubMed ID: 8781412
[TBL] [Abstract][Full Text] [Related]
11. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells.
Breig O; Théoleyre-Schaal O; Baklouti F
Cell Signal; 2013 Dec; 25(12):2453-61. PubMed ID: 23993958
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
[TBL] [Abstract][Full Text] [Related]
14. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
[TBL] [Abstract][Full Text] [Related]
15. Epo-induced erythroid maturation is dependent on Plcγ1 signaling.
Schnöder TM; Arreba-Tutusaus P; Griehl I; Bullinger L; Buschbeck M; Lane SW; Döhner K; Plass C; Lipka DB; Heidel FH; Fischer T
Cell Death Differ; 2015 Jun; 22(6):974-85. PubMed ID: 25394487
[TBL] [Abstract][Full Text] [Related]
16. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells.
Garçon L; Rivat C; James C; Lacout C; Camara-Clayette V; Ugo V; Lecluse Y; Bennaceur-Griscelli A; Vainchenker W
Blood; 2006 Sep; 108(5):1551-4. PubMed ID: 16684963
[TBL] [Abstract][Full Text] [Related]
18. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
[TBL] [Abstract][Full Text] [Related]
19. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
[TBL] [Abstract][Full Text] [Related]
20. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
